Sendrowski David P, Bronstein Mark A
Ocular Disease, Southern California College of Optometry, 2575 Yorba Linda Blvd., Fullerton, CA 92831, USA.
Optometry. 2010 Mar;81(3):157-61. doi: 10.1016/j.optm.2009.09.018.
Vitreous floaters are a common complaint in the ophthalmic care setting. Patients seek explanation and advice regarding possible treatment options. Because the condition is considered benign, ophthalmic care practitioners have little to offer regarding treatment options. The majority of cases encountered are managed with patient education and reassurance. Although almost all patients accept the conservative management option, there is a small subset of patients who may desire a more aggressive treatment intervention for resolution of their visual symptoms. Information with regard to treatment options is readily available to patients through Internet searches and non-peer reviewed educational Web sites. The risks and benefits for these treatment options are not fully covered. Management of floaters should include education regarding "off-label" procedures as well as discussion about benefits and risks associated with such treatment options. It is vital that eye care practitioners advise and counsel patients with symptomatic floaters for optimum ocular health care. This article reviews the current conventional and "off-label" treatment options for symptomatic patients with vitreous floaters.
玻璃体混浊是眼科护理中常见的主诉。患者寻求关于可能治疗方案的解释和建议。由于该病症被认为是良性的,眼科护理从业者在治疗方案方面几乎没有什么可提供的。遇到的大多数病例通过对患者进行教育和安抚来处理。尽管几乎所有患者都接受保守治疗方案,但仍有一小部分患者可能希望采取更积极的治疗干预措施来消除视觉症状。患者可以通过互联网搜索和未经同行评审的教育网站轻松获取有关治疗方案的信息。这些治疗方案的风险和益处并未得到充分涵盖。玻璃体混浊的管理应包括关于“非标签”程序的教育,以及对此类治疗方案相关益处和风险的讨论。眼科护理从业者为有症状的玻璃体混浊患者提供建议和咨询,以实现最佳的眼部保健,这至关重要。本文综述了有症状的玻璃体混浊患者当前的传统和“非标签”治疗方案。